mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunization
Cell Host & Microbe · 2024
DOI: 10.1016/j.chom.2024.10.014 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Host & Microbe, 2024. Verfasst von Xiaonan Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. Hauptthemen laut MEDLINE: mRNA Vaccines, Poxviridae Infections, Smallpox Vaccine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
In recent work, Mucker et al.1 demonstrated that mRNA-1769 outperforms modified vaccinia Ankara (MVA), which has been deployed against recent mpox virus (MPXV) outbreaks, in reducing clinical symptoms and controlling viral replication, highlighting its potential as a scalable, safe, and effective next-generation platform for orthopoxvirus vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
- Changping Laboratory, Beijing, China.
- Changping Laboratory, Beijing, China. Electronic address: yanjh@cpl.ac.cn.
Zitieren
APA
Han, X., Huang, Q., & Yan, J. (2024). mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunization. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2024.10.014
Vancouver
Han X, Huang Q, Yan J. mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunization. Cell Host & Microbe. 2024. doi:10.1016/j.chom.2024.10.014
BibTeX
@article{Han2024,
author = {Han, Xiaonan and Huang, Qingrui and Yan, Jinghua},
title = {mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunization},
journal = {Cell Host & Microbe},
year = {2024},
doi = {10.1016/j.chom.2024.10.014}
}
EUVIMED